Merit Medical Systems (NASDAQ:MMSI) Reaches New 52-Week Low – Should You Sell?

Merit Medical Systems, Inc. (NASDAQ:MMSI)’s share price reached a new 52-week low on Wednesday . The stock traded as low as $73.87 and last traded at $74.85, with a volume of 525945 shares. The stock had previously closed at $76.50.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Weiss Ratings reiterated a “hold (c)” rating on shares of Merit Medical Systems in a report on Monday, December 29th. Needham & Company LLC cut their price objective on Merit Medical Systems from $108.00 to $101.00 and set a “buy” rating for the company in a research report on Wednesday, February 25th. Barrington Research lifted their target price on Merit Medical Systems from $106.00 to $109.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 25th. Canaccord Genuity Group increased their price target on Merit Medical Systems from $93.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, December 17th. Finally, Wells Fargo & Company cut shares of Merit Medical Systems from an “overweight” rating to an “equal weight” rating and reduced their price objective for the stock from $95.00 to $78.00 in a research report on Thursday, February 26th. Eight investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Merit Medical Systems presently has an average rating of “Moderate Buy” and an average target price of $103.33.

Merit Medical Systems Stock Performance

The company has a fifty day moving average of $82.50 and a two-hundred day moving average of $84.55. The firm has a market capitalization of $4.37 billion, a price-to-earnings ratio of 34.67, a PEG ratio of 2.15 and a beta of 0.62. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.95 and a current ratio of 4.34.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings data on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.08. The firm had revenue of $393.94 million for the quarter, compared to analysts’ expectations of $390.77 million. Merit Medical Systems had a return on equity of 13.82% and a net margin of 8.48%.The company’s quarterly revenue was up 10.9% compared to the same quarter last year. During the same quarter last year, the business earned $0.93 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. As a group, equities research analysts predict that Merit Medical Systems, Inc. will post 3.37 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the business. AQR Capital Management LLC raised its position in shares of Merit Medical Systems by 7.3% in the first quarter. AQR Capital Management LLC now owns 16,361 shares of the medical instruments supplier’s stock valued at $1,730,000 after buying an additional 1,114 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Merit Medical Systems by 16.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 719,313 shares of the medical instruments supplier’s stock worth $76,039,000 after acquiring an additional 103,878 shares during the period. Amalgamated Bank raised its holdings in Merit Medical Systems by 1.1% in the 2nd quarter. Amalgamated Bank now owns 16,773 shares of the medical instruments supplier’s stock valued at $1,568,000 after acquiring an additional 186 shares in the last quarter. Bank of New York Mellon Corp lifted its position in shares of Merit Medical Systems by 0.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 428,084 shares of the medical instruments supplier’s stock valued at $40,017,000 after acquiring an additional 2,261 shares during the period. Finally, Bryn Mawr Trust Advisors LLC grew its holdings in shares of Merit Medical Systems by 7.2% during the 2nd quarter. Bryn Mawr Trust Advisors LLC now owns 2,225 shares of the medical instruments supplier’s stock worth $208,000 after purchasing an additional 149 shares in the last quarter. Institutional investors and hedge funds own 99.66% of the company’s stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.